Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/28/16 → 03/1/20 |
Funding
- Vertex Pharmaceuticals Incorporated: $19,930.00
A Phase 2, Randomized, Double blind, Controlled Study to Evaluate the Safety and Efficacy of VX-440 Combination Therapy in Subjects Aged 12 Years and Older With Cystic Fibrosis
- Frederick, Carla (PI)
- Baker, Susan (CoI)
Project: Research